Bio Diagnostics Businesses for Sale

Company: 25-year-old bio-diagnostics manufacturer based in Amman, Jordan, specializing in in vitro diagnostic reagents and medical lab reagent kits. - Workforce & scale: 63 employees operating US FDA- and CE-certified production and quality-control facilities. - Product line: Reagents and complete diagnostic kits used to measure analytes in human blood, urine, and stool for clinical chemistry and medical laboratories. - Production capacity: Able to produce 6,000 vials/day or ~1,000 kits/day, nominally ~24,000 kits/month at regular shifts; with overtime reaches ~30,000–35,000 kits/month. - Market coverage: Export-focused business selling to ~90 countries via dealer network; active dealers in 70+ countries across the USA, LATAM, Europe (strong in Germany and other EU markets), MENA (notably KSA), West Asia, Southeast Asia, Africa, and the Americas. - Customer profile: Primary customers are small-to-medium medical labs and diagnostic centers that consume 50–60% of the company’s routine reagent portfolio. Dealers/distributors serve larger regional purchasing and logistics. - Competitive strengths: Regulatory certifications (USFDA, CE), long industry track record, broad geographic distribution, and capacity to scale production to meet rising lab reagent demand. - Sales channels & monetization: Revenue generated through wholesale sales to dealers, direct bulk orders from clinical labs, and repeat sales of consumable reagents and diagnostic kits (recurring revenue from per-test consumables). - Monthly revenue depends on the number and size of orders, not on the number of employees.

Company: 25-year-old bio-diagnostics manufacturer based in Amman, Jordan, specializing in in vitro diagnostic reagents and medical lab reagent kits. - Workforce & scale: 63 employees operating US FDA- and CE-certified production and quality-control facilities. - Product line: Reagents and complete diagnostic kits used to measure analytes in human blood, urine, and stool for clinical chemistry and medical laboratories. - Production capacity: Able to produce 6,000 vials/day or ~1,000 kits/day, nominally ~24,000 kits/month at regular shifts; with overtime reaches ~30,000–35,000 kits/month. - Market coverage: Export-focused business selling to ~90 countries via dealer network; active dealers in 70+ countries across the USA, LATAM, Europe (strong in Germany and other EU markets), MENA (notably KSA), West Asia, Southeast Asia, Africa, and the Americas. - Customer profile: Primary customers are small-to-medium medical labs and diagnostic centers that consume 50–60% of the company’s routine reagent portfolio. Dealers/distributors serve larger regional purchasing and logistics. - Competitive strengths: Regulatory certifications (USFDA, CE), long industry track record, broad geographic distribution, and capacity to scale production to meet rising lab reagent demand. - Sales channels & monetization: Revenue generated through wholesale sales to dealers, direct bulk orders from clinical labs, and repeat sales of consumable reagents and diagnostic kits (recurring revenue from per-test consumables). - Monthly revenue depends on the number and size of orders, not on the number of employees.